Li'AO Wang

Li'AO Wang

Auto-generated profile, based on publicly available information

Li'AO Wang

Department of Neurosurgery, Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2022 in Neurospine
Verified
Journal Article
Open access
PDF file
LWLiang Wu
Liang Wu
LWLi'AO Wang
Li'AO Wang
JYJun Yang
Jun Yang
WJWenqing Jia
Wenqing Jia
YXYulun Xu
Yulun Xu
Objective: Intramedullary spinal cord metastasis from lung cancer (ISCM-LC) are increasing in prevalence. We aim to investigate its clinical features, treatments and prognosis.Methods: We reported 6 ISCM-LC cases and conducted a systematic review. Descriptive summarization, survival analysis, and multivariate Cox regression analysis were performed to comprehensively study the disease.Results: All 6 patients had surgery. One used chemotherapy and the other had targeted drugs. Two patients died of ISCM-LC, 1 died of pulmonary embolism, 1 was alive, and 2 were lost to follow-up. We identified 197 ISCM-LC cases in literature with a mean age of 58 years and male preponderance. Small cell lung cancer accounted for 39.1%. The median interval from lung cancer to ISCM-LC was 7 months. Limb weakness was the most common symptom, and 45% cases progressed rapidly. Concomitant brain, leptomeningeal, and vertebral metastasis occurred to 55.8%, 20%, and 19.5%, respectively. Peritumoral edema appeared in 83.3%. Through survival analysis, we found sex, extraspinal metastasis, pathology, and improved symptoms affected the overall survival. Additionally, gross total resection (GTR) shared similar effectiveness with non-GTR, and other treatments following surgery hardly added extra effect. Surgery, improved symptoms, and sex were 3 independent prognostic factors after adjusting for confounding. The estimated median survival time was 5 months.Conclusion: The overall survival of ISCM-LC remains poor. Surgery is an independent protective factor for survival. Surgery should be considered once tolerated, and GTR might not be necessary. In addition, female patients with improved symptoms after intervention might have better overall survival.

4 August 2026 in World Neurosurgery
Verified
Journal Article
Open access
XGXufei Guo
Xufei Guo
SSShiqi Shi
Shiqi Shi
LWLi'AO Wang
Li'AO Wang
LCLiangpeng Chen
Liangpeng Chen
CSChen Sun
Chen Sun
DLDeling Li
Deling Li

16 June 2026 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
LWLi’AO Wang
Li’AO Wang
JXJialin Xiang
Jialin Xiang
LLLinlin Li
Linlin Li
YLYangyang Liu
Yangyang Liu
LCLiangpeng Chen
Liangpeng Chen
DLDeling Li
Deling Li